[{"id":"62643025-1b9c-4a89-a9ab-1626e60edfc3","acronym":"MPCT-012L","url":"https://clinicaltrials.gov/study/NCT05826535","created_at":"2023-04-24T14:04:02.070Z","updated_at":"2025-02-25T14:52:30.983Z","phase":"Phase 1/2","brief_title":"Study of IMPT-314 in R/R Aggressive B-cell NHL","source_id_and_acronym":"NCT05826535 - MPCT-012L","lead_sponsor":"ImmPACT Bio","biomarkers":" BCL2 • BCL6","pipe":" | ","alterations":" BCL6 rearrangement • BCL2 rearrangement","tags":["BCL2 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BCL6 rearrangement • BCL2 rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e rondecabtagene autoleucel (LYL314)"],"overall_status":"Recruiting","enrollment":" Enrollment 150","initiation":"Initiation: 05/09/2023","start_date":" 05/09/2023","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 12/01/2029","study_completion_date":" 12/01/2029","last_update_posted":"2025-01-14"}]